According to Mirum Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$4.75. In 2022 the company made an earnings per share (EPS) of -$4.02 a decrease over its 2021 EPS that were of -$2.80.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$4.75 | 18.18% |
2022 | -$4.02 | 43.51% |
2021 | -$2.80 | -31.41% |
2020 | -$4.08 | 44.97% |
2019 | -$2.81 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -54.06% | ๐บ๐ธ USA |